NEW YORK (GenomeWeb News) - Codon Devices plans to open a new UK headquarters to service customers in European markets, the company said today.
 
The Cambridge, Mass.-based synthetic biology firm described the move as a "major step" toward its global expansion goals.
 
Codon Devices said it has appointed Michael Dyson, formerly managing director of Sequenom, to run the UK office and manage the European sales force.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.